stocksfeed.ai
← Back to news feed

BIIB overview

BIIB
Biogen Inc.
251.41
USD
-3.52 (-1.38%)since Nov 16, 2026

News about BIIB

1 story shown

BIIBIONSproduct launch

Biogen announced two-year data from the Phase 2 CELIA study showing that its investigational therapy diranersen slowed clinical decline in early Alzheimer's disease.

Benzinga
View original